Glaukos Investor Relations Material
Latest events
Q1 2025
Glaukos
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Glaukos Corporation
Access all reports
Glaukos Corporation develops and commercializes medical devices and pharmaceuticals for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is known for its minimally invasive surgical technologies and ophthalmic drug delivery platforms. The company is headquartered in Aliso Viejo, California, and its shares are listed on the NYSE.
Key slides for Glaukos Corporation
Investor Presentation
Glaukos Corporation
43rd Annual J.P. Morgan Healthcare Conference 2025
Glaukos Corporation
Latest articles
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
Ticker symbol
GKOS
Country
🇺🇸 United States